Linden Thomas Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Linden Thomas Advisory Services’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.93M	Buy	30,959 +341	+1%	+$21.6K	0.15%	226
2026 Q2	$1.76M	Buy	30,618 +785	+3%	+$45.1K	0.14%	251
2026 Q1	$1.81M	Buy	29,833 +1,818	+6%	+$106K	0.17%	212
2025 Q4	$1.51M	Sell	28,015 -199	-0.7%	-$9.6K	0.15%	207
2025 Q3	$1.27M	Buy	28,214 +416	+1%	+$19.4K	0.13%	250
2025 Q2	$1.29M	Buy	27,798 +1,056	+4%	+$51.8K	0.14%	230
2025 Q1	$1.63M	Buy	26,742 +639	+2%	+$37.2K	0.21%	175
2024 Q4	$1.48M	Sell	26,103 -509	-2%	-$28.4K	0.19%	203
2024 Q3	$1.38M	Sell	26,612 -266	-1%	-$12.5K	0.19%	215
2024 Q2	$1.12M	Sell	26,878 -15,660	-37%	-$701K	0.17%	244
2024 Q1	$2.31M	Buy	42,538 +2,773	+7%	+$141K	0.37%	60
2023 Q4	$2.04M	Buy	39,765 +1,316	+3%	+$69.1K	0.38%	62
2023 Q3	$2.23M	Buy	38,449 +13,488	+54%	+$826K	0.5%	30
2023 Q2	$1.6M	Buy	24,961 +728	+3%	+$48.8K	0.35%	89
2023 Q1	$1.68M	Buy	24,233 +2,476	+11%	+$175K	0.42%	68
2022 Q4	$1.57M	Buy	+21,757	New	+$1.64M	0.44%	67

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Linden Thomas Advisory Services's BMY Position: Q3 2026 in Review

Linden Thomas Advisory Services increased its Bristol-Myers Squibb (BMY) stake by 1.1% in Q3 2026, buying an estimated $21.6K and bringing the position to 30,959 shares worth $1.93M. The position accounts for 0.15% of the portfolio, ranked #226.

Linden Thomas Advisory Services first reported a position in BMY in Q4 2022 and has held it in 16 quarters since. The position peaked at $2.31M in Q1 2024. 907 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

Linden Thomas Advisory Services held 30,959 shares of Bristol-Myers Squibb worth $1.93M as of Q3 2026.
Linden Thomas Advisory Services bought 341 Bristol-Myers Squibb shares in Q3 2026, an estimated $21.6K.
Bristol-Myers Squibb made up 0.15% of Linden Thomas Advisory Services's portfolio in Q3 2026, its #226 holding.
Linden Thomas Advisory Services first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 16 quarters since.
Linden Thomas Advisory Services's Bristol-Myers Squibb position peaked at $2.31M in Q1 2024.
907 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.